Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases
Authors:
Open Access
- 18 January 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 12, 1349077
Abstract
Gene therapy is a technique that rectifies defective or abnormal genes by introducing exogenous genes into target cells to cure the disease. Although gene therapy has gained some accomplishment for the diagnosis and therapy of inherited or acquired cardiovascular diseases, how to efficiently and specifically deliver targeted genes to the lesion sites without being cleared by the blood system remains challenging. Based on nanotechnology development, the non-viral vectors provide a promising strategy for overcoming the difficulties in gene therapy. At present, according to the physicochemical properties, nanotechnology-based non-viral vectors include polymers, liposomes, lipid nanoparticles, and inorganic nanoparticles. Non-viral vectors have an advantage in safety, efficiency, and easy production, possessing potential clinical application value when compared with viral vectors. Therefore, we summarized recent research progress of gene therapy for cardiovascular diseases based on commonly used non-viral vectors, hopefully providing guidance and orientation for future relevant research.Keywords
This publication has 134 references indexed in Scilit:
- Promising plasmid DNA vector based on APTES-modified silica nanoparticlesInternational Journal of Nanomedicine, 2012
- Gold Nanoparticles: A Revival in Precious Metal Administration to PatientsNano Letters, 2011
- Delivery of nanoparticle‐complexed drugs across the vascular endothelial barrier via caveolaeIUBMB Life, 2011
- Synthesis and characterization of new poly(ortho ester amidine) copolymers for non-viral gene deliveryPolymer, 2011
- Targeted Delivery of Nanoparticles to Ischemic Muscle for Imaging and Therapeutic AngiogenesisNano Letters, 2010
- Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac functionThe FASEB Journal, 2009
- Effects of nanomaterial physicochemical properties on in vivo toxicityAdvanced Drug Delivery Reviews, 2009
- Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNADiscover Nano, 2009
- Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodelingParticle and Fibre Toxicology, 2009
- Cardiovascular gene therapyThe Lancet, 2000